News

September 22, 2016September 22, 2016

Inventiva Awarded €2.3M to Turn YAP/TEAD Research into Mesothelioma Treatments

News

Inventiva announced that it has received two grants, worth a total of €2.3 million, for its YAP/TEAD protein research program that is focused on developing molecules with the potential to significantly treat malignant mesothelioma, as well as severe ... Read more

September 21, 2016September 21, 2016

Malignant Pleural Mesothelioma May Be Effectively Treated with Combined Therapy Approach

News

Using a dual therapeutic approach targeting both MET and PI3K signaling pathways is more effective in treating malignant pleural mesothelioma (MPM) cells than using each inhibitor alone, according to a study recently ... Read more

September 20, 2016September 20, 2016

FDA Moves Galinpepimut-S, Potential Immunotherapy for Malignant Pleural Mesothelioma, to ‘Fast Track’

News

The U.S. Food and Drug Administration has granted Fast Track designation to SELLAS Life Sciences‘ WT1 cancer vaccine — galinpepimut-S — as a possible treatment of malignant pleural mesothelioma. This action ... Read more

September 19, 2016September 20, 2016

Phase 2 Study of Potential Treatment for Pleural Mesothelioma Now Recruiting Patients

News

The Baylor College of Medicine’s Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center has began recruiting patients with malignant pleural mesothelioma in a clinical trial to test an investigational ... Read more

September 16, 2016September 16, 2016

SELLAS Collaborates with NIH to Develop Gene-Monitoring Assay for Cancer Immunotherapies

News

SELLAS Life Sciences has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. National Heart, Lung and Blood Institute of the National Institutes of Health (NIH). CRADA ... Read more

September 15, 2016

Study Identifies Signs Associated with Reoperative Surgery in Peritoneal Mesothelioma Patients

News

Abdominal pain, abdominal distention, and the presence of a tumor mass in computed tomography scans are all associated with the recurrence of malignant peritoneal mesothelioma following surgical removal of the tumor, ... Read more

September 14, 2016

Study Reveals How Mesothelioma Cells Become Resistant to Resveratrol, Chemotherapy Combo

News

Combining the platinum chemotherapeutic drug Platinol (cisplatin) with the plant-based compound resveratrol increased cell death of malignant mesothelioma cells grown in the lab, but the effectiveness of the treatment varied ... Read more

September 13, 2016

Novel Biomarker in Mesothelioma May Be Targeted to Improve Sensitivity to Chemotherapy

News

Researchers at the Nagoya University Graduate School of Medicine in Japan have shown that increased levels of a cell surface protein called urokinase-type plasminogen activator receptor (uPAR) are associated with poor prognosis in ... Read more

September 12, 2016November 14, 2016

Finding Out About Mesothelioma Clinical Trials

News

The research community is working to discover and evaluate new mesothelioma treatments that might greatly improve patient outcomes and, potentially, lead to a cure. Yet many people are unaware that clinical trials are currently enrolling mesothelioma ... Read more

September 12, 2016September 12, 2016

Exosomes Secreted by Malignant Mesothelioma Cells May Work as Diagnostic Marker

News

Malignant mesothelioma cells can secrete tiny vesicles containing a variety of proteins that educate the tumor microenvironment and lead to disease progression. In a recent study published in Scientific Reports, researchers identified the ... Read more